IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
635.40
-1.94 (-0.30%)
Oct 17, 2025, 4:00 PM EDT - Market closed
IDEXX Laboratories Revenue
IDEXX Laboratories had revenue of $1.11B in the quarter ending June 30, 2025, with 10.55% growth. This brings the company's revenue in the last twelve months to $4.04B, up 6.68% year-over-year. In the year 2024, IDEXX Laboratories had annual revenue of $3.90B with 6.46% growth.
Revenue (ttm)
$4.04B
Revenue Growth
+6.68%
P/S Ratio
12.82
Revenue / Employee
$367,065
Employees
11,000
Market Cap
50.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.90B | 236.55M | 6.46% |
| Dec 31, 2023 | 3.66B | 293.63M | 8.72% |
| Dec 31, 2022 | 3.37B | 151.96M | 4.73% |
| Dec 31, 2021 | 3.22B | 508.71M | 18.79% |
| Dec 31, 2020 | 2.71B | 299.75M | 12.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
IDXX News
- 11 days ago - IDEXX Laboratories to Release 2025 Third Quarter Financial Results - Business Wire
- 12 days ago - IDEXX Laboratories Elects Karen Peacock to Board of Directors - Business Wire
- 5 weeks ago - IDEXX Laboratories, Inc. (IDXX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - IDEXX Laboratories to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference - Business Wire
- 2 months ago - Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts - Seeking Alpha
- 2 months ago - S&P 500 Gains and Losses Today: Retail Sector Stocks Rise Amid Rate Cut Hopes - Investopedia
- 2 months ago - IDEXX Laboratories, Inc. (IDXX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Top Stock Movers Now: IDEXX, Wayfair, Berkshire Hathaway, and More - Investopedia